Compass Point lowered the firm’s price target on Kinsale Capital to $390 from $490 and keeps a Neutral rating on the shares. While the firm notes that it has described Kinsale as “the gold standard in specialty E&S insurance,” it adds that it is mindful that “investors need to be extra discriminating about entry points with KNSL that offer reasonable potential rates of return.” There comes a time when circumstances impair the growth rate and lead to a period of valuation compression, and “we can’t ignore the potential risk that this may be occurring at KNSL,” the analyst added.
Click Here to Read the Full Original Article at TipRanks Financial Blog…
